NITE, Genome Pharmaceuticals Institute Jointly Explore Rare Actinomycetes for MRSA

January 28, 2019
The National Institute of Technology and Evaluation (NITE) said on January 25 that it has commenced a joint research project with the biotech company Genome Pharmaceuticals Institute to assess the antibacterial activity of culture extracts of rare actinomycetes. Earlier, NITE...read more